Fosinopril and Hydrochlorothiazide and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Fosinopril and Hydrochlorothiazide and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: fosinopril / hydrochlorothiazide
Brand name: Monopril HCT
Synonyms: Hydrochlorothiazide and fosinopril
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Fosinopril and Hydrochlorothiazide-Insulin glargine, recombinant Subcutaneous
- Fosinopril and Hydrochlorothiazide-Insulin glulisine
- Fosinopril and Hydrochlorothiazide-Insulin Glulisine (Cartridges and Pens)
- Fosinopril and Hydrochlorothiazide-Insulin Glulisine (Vials)
- Fosinopril and Hydrochlorothiazide-Insulin glulisine Subcutaneous
- Fosinopril and Hydrochlorothiazide-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Fosinopril Sodium
- Insulin glargine and lixisenatide Subcutaneous-Fosnetupitant and Palonosetron
- Insulin glargine and lixisenatide Subcutaneous-Fosnetupitant and palonosetron injection
- Insulin glargine and lixisenatide Subcutaneous-Fosnetupitant/palonosetron Intravenous
- Insulin glargine and lixisenatide Subcutaneous-Fosphenytoin
- Insulin glargine and lixisenatide Subcutaneous-Fosphenytoin Injection